Guardant Health, Inc. - Common Stock (NQ:GH)

177.80 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research

August 01, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana

July 20, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023

July 12, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan

July 05, 2023

From Guardant Health, Inc.

Via Business Wire

Analyst Ratings for Guardant Health ↗

May 26, 2023

Via Benzinga

Why Shares of Guardant Health Jumped This Week ↗

May 19, 2023

The cancer diagnostic company saw its shares take a big jump for the second straight week.

Via The Motley Fool

Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark ↗

June 23, 2023

On Friday, Guardant Health stock hit a key performance benchmark, with its Relative Strength Rating rising to 82, up from 78 the day before.

Via Investor's Business Daily

Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting

May 31, 2023

From Guardant Health, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2023 ↗

May 26, 2023

Via Benzinga

Guardant Health to Participate in Upcoming June Investor Conferences

May 26, 2023

From Guardant Health, Inc.

Via Business Wire

What 11 Analyst Ratings Have To Say About Guardant Health ↗

May 10, 2023

Via Benzinga

Guardant Health Shares Move Lower On $350M Public Offering: The Details ↗

May 23, 2023

Guardant Health Inc (NASDAQ: GH) shares are trading lower Tuesday after the company announced an offering.

Via Benzinga

Guardant Health Announces Pricing of Upsized Public Offering of Common Stock

May 22, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Proposed Public Offering of Common Stock

May 22, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling

May 17, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Releases Inaugural ESG Report

May 16, 2023

From Guardant Health, Inc.

Via Business Wire

Why Guardant Health's Shares Climbed This Week ↗

May 11, 2023

The company, which focuses on oncology screenings, saw a big gain in revenue in the first quarter.

Via The Motley Fool

A New Groundbreaking Tool to Detect Colon Cancer Earlier

May 10, 2023

A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...

Via PressReach

Guardant Health Reports First Quarter 2023 Financial Results

May 09, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield™ blood test

May 09, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Additions to Leadership Team

May 08, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces ECLIPSE Study Update Call on May 9, 2023

May 05, 2023

From Guardant Health, Inc.

Via Business Wire

New Artificial Intelligence Tool Can Diagnose Colon Cancer

May 03, 2023

A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and...

Via PressReach

Topics Artificial Intelligence Death

Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023 ↗

May 01, 2023

Via Benzinga

Guardant Health to Participate in the BofA Securities 2023 Healthcare Conference

April 27, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response

April 25, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health announces new data to be presented at 2023 Digestive Disease Week showcasing the potential of its blood-based technology to detect colorectal cancer

April 21, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report First Quarter 2023 Financial Results on May 9, 2023

April 19, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Receives Medicare Coverage for Guardant360 Response™ to Monitor Cancer Patient Response to Immunotherapy

April 18, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting

April 11, 2023

From Guardant Health, Inc.

Via Business Wire

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.